Oramed Pharmaceuticals
ORMP
#9184
Rank
ยฃ0.13 B
Marketcap
ยฃ3.27
Share price
3.10%
Change (1 day)
80.91%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): ยฃ46.64 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of ยฃ47 Million, an increase over its 2024 earnings that were of -ยฃ11.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ46.64 M-0.77%
2025 ยฃ47 M-513.21%
2024 -ยฃ11.38 Million-311.47%
2023 ยฃ5.37 M-119.45%
2022 -ยฃ27.66 Million39.17%
2021 -ยฃ19.88 Million73.93%
2020 -ยฃ11.43 Million18.53%
2019 -ยฃ9.64 Million-16.62%
2018 -ยฃ11.57 Million38.32%
2017 -ยฃ8.36 Million12.51%
2016 -ยฃ7.43 Million25.01%
2015 -ยฃ5.95 Million18.18%
2014 -ยฃ5.03 Million39.72%
2013 -ยฃ3.6 Million46.4%
2012 -ยฃ2.46 Million128.32%
2011 -ยฃ1.08 Million-51.47%
2010 -ยฃ2.22 Million35.21%
2009 -ยฃ1.65 Million
2007 -ยฃ2.58 Million607.04%
2006 -ยฃ0.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
ยฃ17.53 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ5.40 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.39 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ46.15 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ26.33 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel